An epidemiological study of terbinafine (TBF)-resistant dermatophytes was conducted in 2023 as a follow-up to our 2020 and 2022 surveys. Dermatophytes were isolated in 2023 from the same dermatology clinics in Tokyo, Saitama, Shizuoka, and Kumamoto, Japan, as in the previous studies. In total, 311 isolates (122 Trichophyton interdigitale isolates, 1 Trichophyton indotineae isolate, and 188 Trichophyton rubrum isolates) were obtained from 311 human cases of dermatophytosis (195 tinea pedis cases, 54 tinea unguium cases, 28 tinea corporis cases, 27 tinea cruris cases, and 7 tinea manuum cases). Ten strains (1 T. interdigitale strain and 9 T. rubrum strains) were found to be resistant to TBF, and susceptible to efinaconazole, itraconazole, luliconazole, and ravuconazole. The isolation rate of TBF-resistant strains was 2.3% in 2020, 1.4% in 2022, and 3.2% in 2023. We determined the sequences of the squalene epoxidase-encoding gene in 10 TBF-resistant strains, and found that all strains harbored missense and/or deletion mutations. These results indicate that the prevalence of TBF-resistant dermatophytes has increased when compared to the previous studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3314/mmj.24-00020 | DOI Listing |
Mycoses
March 2025
Department of Medical Mycology, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College, Nanjing, Jiangsu, People's Republic of China.
Background: Trichophyton rubrum is one of the most common human pathogenic fungi, with the infections often managed through empirical drug use. However, treatments frequently lead to relapse upon withdrawal. The rise in drug-resistant T.
View Article and Find Full Text PDFBackground and objective Dermatophytosis refers to superficial skin fungal infection in humans. The laboratory diagnosis of the pathogens causing dermatophytosis is challenging. In recent years, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as an effective tool for diagnosing and identifying microorganisms.
View Article and Find Full Text PDFAn epidemiological study of terbinafine (TBF)-resistant dermatophytes was conducted in 2023 as a follow-up to our 2020 and 2022 surveys. Dermatophytes were isolated in 2023 from the same dermatology clinics in Tokyo, Saitama, Shizuoka, and Kumamoto, Japan, as in the previous studies. In total, 311 isolates (122 Trichophyton interdigitale isolates, 1 Trichophyton indotineae isolate, and 188 Trichophyton rubrum isolates) were obtained from 311 human cases of dermatophytosis (195 tinea pedis cases, 54 tinea unguium cases, 28 tinea corporis cases, 27 tinea cruris cases, and 7 tinea manuum cases).
View Article and Find Full Text PDFPathogens
January 2025
Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
Cutaneous fungal infections represent a significant burden worldwide with a high impact on public health. Accurate identification of dermatophyte species causing these infections is vital for an appropriate treatment. Terbinafine is the primary agent against species due to its clinical efficacy; however, cases of elevated minimum inhibitory concentration (MIC) have been reported, raising clinical and epidemiological concerns.
View Article and Find Full Text PDFJ Clin Med
February 2025
Section of Hygiene, Interdisciplinary Department of Medicine, University of Bari "Aldo Moro", Piazza G. Cesare 11, 70124 Bari, Italy.
: Dermatophytosis due to () has spread worldwide, and the acquisition of new drug resistances is making this threat challenging to face. We report four cases of dermatophytosis caused by and perform a systematic review of case reports to explore the most relevant clinical and demographic features and the treatment patterns of this infection. : A literature search, using the PubMed database and following PRISMA guidelines, was performed up to the 6th of December 2024.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!